Pharmaceutical composition having modified carrier

Details Pharmaceutical composition having modified carrier Pharmaceutical composition having modified carrier

2003-11-10

2010-11-09

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S450000, C514S012200

Reexamination Certificate

active

07829100

ABSTRACT:
A composition comprising:(a) one to three bioactive agents; and(b) a modified liquid vehicle;wherein immediately after manufacture of the composition, said composition can be administered to a host such that the one to three bioactive agents is released to the host on a sustained basis is provided.

REFERENCES:
patent: 4297353 (1981-10-01), Maulding
patent: 5013713 (1991-05-01), Mitchell
patent: 5019395 (1991-05-01), Mahjour et al.
patent: 5162057 (1992-11-01), Akiyama et al.
patent: 5721359 (1998-02-01), Dunn et al.
patent: 5736151 (1998-04-01), Foster et al.
patent: 5739159 (1998-04-01), Wolf
patent: 6074657 (2000-06-01), Brown
patent: WO 94/00105 (1994-01-01), None
patent: WO 96/20698 (1996-07-01), None
patent: WO 97/49402 (1997-12-01), None
patent: WO 98/41207 (1998-09-01), None
Matheson Tri-Gas, Inc. Ethylene Oxide MSDS. Downloaded Dec. 22, 2006 from http://www.thesontrigas.com/pdfs/msds/MAT09520.pdf.
Remington, The Science and Practice of Pharmacy. 20th Edition, p. 765, 2000.

Affiliated with

Also associated with

Rating

Pharmaceutical composition having modified carrier does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition having modified carrier, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition having modified carrier will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4223889